FFR-Guided PCI Matches CABG in Long-Term Outcomes
Final 5-Year Follow-up result of the FAME 3 Trial
Current Challenges and Future Directions in Valve-in-Valve Procedures
Problems and Solutions for ViV
Lessons Learned from EARLY TAVR Trial
New Paradigm for Asymptomatic Severe AS
Preparing Second Attempt for Previous Failed CTO PCI
Clinical and Technical Considerations for Reintervention in CTO
Selection of the Appropriate Atherectomy Device for Coronary Calcium
‘Severely calcified lesions: What is the best technique/lessons from the ECLIPSE trial.’
Rule of 6-8-12 for Left Main Upfront 2-Stenting
Prof. Jung-Min Ahn Introduces the “6-8-11 Rule” to Redefine Left Main PCI at TCTAP 2025
Temporal Decoupling Ischemic and Bleeding Risks After Complex PCI; TAILORED-CHIP Trial and Others
Future Antiplatelet Strategy to Redefine Complex PCI Care: TAILORED-CHIP Trial Will Inspire Temporal Modulation of Dual Antiplatelet Therapy
Novel Insights of Preventive PCI for Non-flow-limiting Vulnerable Plaques
Lessons From PREVENT Trial and Subgroup Analysis
Interventional Cardiology at Crossroads: A Bright Future of Collaboration; From Intervention to Prevention
Special Lecture by the 15th TCTAP Master of the Masters Award Recipient
[New RCTs from AMC] Antithrombotic Therapy for AF and CAD: EPIC-CAD Trial and More
Optimizing Antithrombotic Strategies in Patients with Atrial Fibrillation and Stable Coronary Disease
[New RCTs from AMC] Most Updated Perioperative Antiplatelet Strategy Post-PCI: ASSURE-DES and More
Perioperative Antiplatelet Strategy In Patients Who Underwent Percutaneous Coronary Intervention: From ASSURE-DES
AI in Coronary Imaging: On the Brink of Mainstream Adoption
Mainstream or a Niche Research tool?
DM and Three-Vessel Disease: Why We Need New RCTS- DEFINE-DM Trial
Can Modern PCI Rival CABG in Diabetic Multivessel CAD?
How Art and Science Work Together to Advance New Device Technology
Art and Science: A Complementary Journey of Problem-Solving